Carbidopa/levodopa/entacapone is contraindicated in patients taking a class of antidepressant drugs known as non-selective monoamine oxidase (MAO) inhibitors such as phenelzine and tranylcypromine [REF].
Carbidopa/levodopa/entacapone may be combined with the drugs rasagiline or selegiline.